Author

Achaiah Garlapati

Observed names: A Garlapati, Achaiah G, Achaiah G., G. ACHAIAH, Garlapati Achaiah, Garlapati, Achaiah

Observed institution: Kakatiya University

ORCID: 0000-0002-6699-4744

Observed ORCID: 0000-0002-6699-4744

OpenAlex ID: A5029684658

Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines

2011 · Kalam Sirisha, Darna Bikshapathi, et al. · European Journal of Medicinal Chemistry · 95

Facile Synthesis and Antibacterial, Antitubercular, and Anticancer Activities of Novel 1,4‐Dihydropyridines

2010 · Kalam Sirisha, Garlapati Achaiah, et al. · Archiv der Pharmazie · 93

Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines

2010 · Saritha Jyostna Tangeda, Achaiah Garlapati · European Journal of Medicinal Chemistry · 53

Design, synthesis, in silico studies, and evaluation of novel chalcones and their pyrazoline derivatives for antibacterial and antitubercular activities

2020 · Shivani Pola, Karan Kumar Banoth, et al. · Medicinal Chemistry Research · 42

Quaternary salts of 4,3′ and 4,4′ bis-pyridinium monooximes: Synthesis and biological activity

2005 · Srinivas Rao Chennamaneni, Venkateswarlu Vobalaboina, et al. · Bioorganic & Medicinal Chemistry Letters · 42

Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives

2022 · Vinayak Walhekar, Chandrakant Bagul, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 39

Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors

2011 · Kalam Sirisha, Maddela Chandra Shekhar, et al. · Bioorganic & Medicinal Chemistry · 31

Quaternary salts of 4,3′ and 4,4′ bis-pyridinium monooximes. Part 2: Synthesis and biological activity

2006 · Chennamaneni Srinivas Rao, Vobalaboina Venkateswarlu, et al. · Bioorganic & Medicinal Chemistry Letters · 27

Strategies to design pyrazolyl urea derivatives for p38 kinase inhibition: a molecular modeling study

2007 · Ravindra G. Kulkarni, Palukuri Srivani, et al. · Journal of Computer-Aided Molecular Design · 20

Synthesis, Characterization, Antitubercular and Anti-Inflammatory Activity of New Pyrazolo[3,4-d]Pyrimidines

2020 · Ravindra Kulkarni, Krishna Kompalli, et al. · Combinatorial Chemistry & High Throughput Screening · 19

Synthesis, p38 Kinase Inhibitory and Anti-inflammatory Activity of New Substituted Benzimidazole Derivatives

2012 · Ravindra G. Kulkarni, Stefan A. Laufer, et al. · Medicinal Chemistry · 19

Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: Synthesis and SAR studies

2014 · Anuradha Doma, Ravindra Kulkarni, et al. · Bioorganic & Medicinal Chemistry · 18

Synthesis and Cytotoxic Activity of New Chalcones and their Flavonol Derivatives

2017 · Rathnakar Reddy Kotha, Ravindra G Kulkarni, et al. · Medicinal Chemistry · 13

Design, Synthesis and Characterization of N', N'-Diaryl Ureas as p38 Kinase Inhibitors

2013 · Ravindra G. Kulkarni, Stefan Laufer, et al. · Medicinal Chemistry · 13

Molecular hybridization based design and synthesis of new benzo[5,6]chromeno[2,3-b]-quinolin-13(14H)-one analogs as cholinesterase inhibitors

2021 · Baswaraju Macha, Ravindra Kulkarni, et al. · Medicinal Chemistry Research · 12

Computational Modelling Strategies for Exploring Triazolopyridazine PIM1 Kinase Inhibitors as Anticancer Agents

2022 · Vinayak Walhekar, Chandrakant Bagul, et al. · Anti-Cancer Agents in Medicinal Chemistry · 9

Synthesis, Antibacterial, Antifungal and Antitubercular Activities of N-Pyrazolylbenzamide Derivatives

2014 · Ravindra Kulkarni, Vijaykumar, et al. · Medicinal Chemistry · 9

Design, Synthesis and Pharmacological Evaluation of Some C3 Heterocyclic-Substituted Ciprofloxacin Derivatives as Chimeric Antitubercular Agents

2020 · Nakka Niveditha, Munnisa Begum, et al. · Chemical and Pharmaceutical Bulletin · 8

PDF

Design, Synthesis and Biological Evaluation of New Cycloalkyl Fused Quinolines Tethered to Isatin Schiff Bases as Cholinesterase Inhibitors

2020 · Baswaraju Macha, Ravindra Kulkarni, et al. · Combinatorial Chemistry & High Throughput Screening · 7

Diseño, síntesis y estudio de acoplamiento molecular de híbridos de quinazolinona-tiazolidin-4-onas como agentes anticancerígenos

2018 · Sukanya Nara, Achaiah Garlapati · Ars Pharmaceutica (Internet) · 7

Synthesis, anticancer and MRP1 inhibitory activities of 4-alkyl/aryl-3,5-bis(carboethoxy/carbomethoxy)-1,4-dihydro-2,6-dimethylpyridines

2012 · Srinivas Nayak Amgoth, Mahendar Porika, et al. · Medicinal Chemistry Research · 6

Design and Friedlander Reaction Based Synthesis of New Cycloalkyl Ring Fused Quinolines as Multifunctional Agents for Alzheimer's Treatment: In Silico Studies

2021 · Baswaraju Macha, Ravindra Kulkarni, et al. · ChemistrySelect · 5

Synthesis and Evaluation of New Brominated Azaflavones and Azaflavanone Derivatives as Cytotoxic agents against Breast Cancer Cell Line (MCF-7)

2019 · Srujana Muthadi, Baswaraju Macha, et al. · Indian Journal of Pharmaceutical Education and Research · 3

PDF

Identification of potential inhibitors of Mtb InhA: a pharmacoinformatics approach

2023 · Sreelatha Kamera, Vishnu Kumar Sharma, et al. · Journal of Biomolecular Structure and Dynamics · 2

Simultaneous Estimation of Lamivudine, Didanosine and Efavirenz in Bulk and their Formulation by UPLC

2022 · Srivani Mallepelli, Sreelatha Kamera, et al. · International Journal of Pharmaceutical Investigation · 2

Works count: 43

Citation count: 602

H-index: 13

I10-index: 15